| Giant cell tumor of bone M Campanacci, GP Bagnara, M Serra, M Giovannini, P Tomasi, S Pileri, ... Tumori 75 (4), 389-395, 1989 | 1758 | 1989 |
| Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents EP Buddingh, ML Kuijjer, RAJ Duim, H Bürger, K Agelopoulos, ... Clinical Cancer Research 17 (8), 2110-2119, 2011 | 453 | 2011 |
| Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome N Baldini, K Scotlandi, G Barbanti-Bròdano, MC Manara, D Maurici, ... New England Journal of Medicine 333 (21), 1380-1385, 1995 | 449 | 1995 |
| Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors K Scotlandi, MC Manara, G Nicoletti, PL Lollini, S Lukas, S Benini, S Croci, ... Cancer research 65 (9), 3868-3876, 2005 | 334 | 2005 |
| Modulation of the osteosarcoma expression phenotype by microRNAs HM Namløs, LA Meza-Zepeda, T Barøy, IHG Østensen, SH Kresse, ... PloS one 7 (10), e48086, 2012 | 299 | 2012 |
| Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target K Scotlandi, S Benini, M Sarti, M Serra, PL Lollini, D Maurici, P Picci, ... Cancer research 56 (20), 4570-4574, 1996 | 292 | 1996 |
| Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice K Scotlandi, S Benini, P Nanni, PL Lollini, G Nicoletti, L Landuzzi, M Serra, ... Cancer research 58 (18), 4127-4131, 1998 | 251 | 1998 |
| An update on chemotherapy for osteosarcoma S Ferrari, M Serra Expert opinion on pharmacotherapy 16 (18), 2727-2736, 2015 | 227 | 2015 |
| Functional characterization of osteosarcoma cell lines provides representative models to study the human disease AB Mohseny, I Machado, Y Cai, KL Schaefer, M Serra, PCW Hogendoorn, ... Laboratory Investigation 91 (8), 1195-1205, 2011 | 222 | 2011 |
| Genome-wide association study identifies two susceptibility loci for osteosarcoma SA Savage, L Mirabello, Z Wang, JM Gastier-Foster, R Gorlick, C Khanna, ... Nature genetics 45 (7), 799-803, 2013 | 200 | 2013 |
| Molecular characterization of commonly used cell lines for bone tumor research: A trans‐European EuroBoNet effort L Ottaviano, KL Schaefer, M Gajewski, W Huckenbeck, S Baldus, U Rogel, ... Genes, Chromosomes and Cancer 49 (1), 40-51, 2010 | 196 | 2010 |
| EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations. M Giovannini, JA Biegel, M Serra, JY Wang, YH Wei, L Nycum, ... Journal of Clinical Investigation 94 (2), 489, 1994 | 188 | 1994 |
| Analysis of heritability and shared heritability based on genome-wide association studies for 13 cancer types JN Sampson, WA Wheeler, M Yeager, O Panagiotou, Z Wang, SI Berndt, ... JNCI Journal of the National Cancer Institute 107 (12), 2015 | 185 | 2015 |
| Local recurrence and local control of non‐metastatic osteosarcoma of the extremities: A 27‐year experience in a single institution G Bacci, C Forni, A Longhi, S Ferrari, M Mercuri, F Bertoni, M Serra, ... Journal of surgical oncology 96 (2), 118-123, 2007 | 184 | 2007 |
| Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing’s sarcoma cells S Benini, MC Manara, N Baldini, V Cerisano, M Serra, M Mercuri, ... Clinical Cancer Research 7 (6), 1790-1797, 2001 | 181 | 2001 |
| Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome K Scotlandi, D Remondini, G Castellani, MC Manara, F Nardi, L Cantiani, ... Journal of Clinical Oncology 27 (13), 2209-2216, 2009 | 167 | 2009 |
| Overcoming Glutathione S-Transferase P1–Related Cisplatin Resistance in Osteosarcoma M Pasello, F Michelacci, I Scionti, CM Hattinger, M Zuntini, AM Caccuri, ... Cancer research 68 (16), 6661-6668, 2008 | 160 | 2008 |
| miR‐34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo‐sensitivity and malignancy F Nakatani, M Ferracin, MC Manara, S Ventura, V Del Monaco, S Ferrari, ... The Journal of pathology 226 (5), 796-805, 2012 | 159 | 2012 |
| Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing’s sarcoma K Scotlandi, MC Manara, CM Hattinger, S Benini, S Perdichizzi, M Pasello, ... European journal of cancer 41 (9), 1349-1361, 2005 | 153 | 2005 |
| Gene amplifications in osteosarcoma—CGH microarray analysis J Atiye, M Wolf, S Kaur, O Monni, T Böhling, A Kivioja, É Tas, M Serra, ... Genes, Chromosomes and Cancer 42 (2), 158-163, 2005 | 143 | 2005 |
Fredrik MertensDepartment of Clinical Genetics, Lund University在 med.lu.se 的电子邮件经过验证
Fredrik MertensDepartment of Clinical Genetics, Lund University在 med.lu.se 的电子邮件经过验证